ClinConnect ClinConnect Logo
Search / Trial NCT06488443

Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals

Launched by UNIVERSITY OF PITTSBURGH · Jun 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Tobacco Dependence Smoking Craving Fagerstorm Test

ClinConnect Summary

This clinical trial is studying how yoga can help people who are dependent on tobacco by reducing their cravings for cigarettes. The researchers want to see if a specific yoga program can be effectively used to support individuals looking to quit tobacco in India. The trial is currently recruiting male participants aged 18 to 65 who have a moderate to high level of tobacco dependence, as measured by a standard test.

To participate, individuals must be tobacco users with a score of 4 or higher on the Fagerstrom test, which assesses dependence on nicotine. However, those with recent alcohol or drug abuse, certain mental health conditions, or physical disabilities that prevent them from doing yoga will not be eligible. Participants can expect to learn yoga techniques that may help them manage cravings and improve their chances of quitting tobacco. This study is important because it aims to find a culturally appropriate way to support tobacco cessation efforts in the community.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • -Tobacco dependent individuals (Fagerstrom test for tobacco dependence score more than or equal to 4)
  • -Men aged 18 to 65 years
  • -Recruited from Rural community health and training centre, Mugalur, Tobacco cessation centre and OPDs of Department of general medicine, pulmonary medicine, cardiology, oncology, ENT and dental surgery and other superspeciality OPD at SJMCH
  • Exclusion Criteria:
  • Patients with recent alcohol use (last 3 months) and use of other drugs of abuse
  • -Patients with clinical diagnosis of Intellectual disability
  • -Comorbid Major mental illness including Dementia, Psychosis, Recurrent depressive disorder, Bipolar affective disorder, OCD, generalized anxiety disorder, Panic disorder and Phobias, diagnosed within the last 6 months.
  • -Patients with recent MI and stroke in the last 3 months or those physically unable to perform the yoga postures due to physical disabilities determined by clinical interview.
  • -Patients with severe hypertension(SBP≥180mmHg and BP≥120mmHg)
  • -Patients with seizures disorder
  • -Patients with COPD(GOLD-2,3 and 4)

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Bengaluru, Karnataka, India

Patients applied

0 patients applied

Trial Officials

Vishwajit Nimgaonkar, MD, PhD

Principal Investigator

University of Pittburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported